United Orthopedic Corporation (TPEX:4129)

Market Cap	10.17B +16.1%
Revenue (ttm)	5.66B +21.5%
Net Income	562.02M +23.2%
EPS	5.67 +19.6%
Shares Out	96.44M
PE Ratio	18.61
Forward PE	15.13
Dividend	4.50 (4.27%)
Ex-Dividend Date	Jul 23, 2025

Volume	16,000
Average Volume	280,647
Open	105.00
Previous Close	105.50
Day's Range	104.00 - 105.00
52-Week Range	83.60 - 131.50
Beta	0.52
RSI	52.74
Earnings Date	May 8, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificia...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.